Manon Couture

This inventor holds 21 USPTO granted patents and 8 published patent applications, plus 20 CIPO patents and 17 EPO patents, primarily in Plant-Based Vaccines. Top assignees: Medicago Inc., Aramis Biotechnologies Inc., Medicago Inc. of Quebec, Canada. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manon Couture. Retrieved from https://idiyas.com/inventor/manon-couture

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 8)

% Patents Active = 95.2

CIPO Patents = 20 (Patent Applications = 3)

EPO Patents = 17 (Patent Applications = 23)

Average Co-Inventor Count = 4.5

ph-index = 4

Forward Citations = 33(Granted Patents)

Location History:

Québec, CA (2014)
St. Augustine de Desmaures, CA (2017)
Saint-Augustin-de-Desmaures, CA (2017)
St-Auqustin-de-Desmaures, CA (2021)
St-Augustin-de-Desmaures, CA (2016 - 2022)
St. Augustin de Desmaures, CA (2016 - 2023)

Company Filing History:

Aramis Biotechnologies Inc.

patents

1 out of 1

Medicago Inc. of Quebec, Canada

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

Areas of Expertise:

Influenza Virus-Like Particles

Plant-Derived Proteins

Transgenic Plants

Hemagglutinin Mutants

VLP Production

Protein Yield

Chimeric Particles

Immunizing Epitope

Recombinant Antigens

Picornavirus-Like Particles

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12467058 - INFLUENZA VIRUS-LIKE PARTICLE PRODUCTION IN PLANTS (2025-11-11),

2. 12428661 - Influenza virus hemagglutinin mutants (2025-09-30),

3. 12139511 - Influenza virus hemagglutinin mutants (2024-11-12),

4. 12104196 - Influenza virus hemagglutinin mutants (2024-10-01),

5. 11833200 - Method of preparing plant-derived proteins (2023-12-05),

6. 11826419 - Method of preparing plant-derived VLPs (2023-11-28),

7. 11434497 - Recombinant influenza virus-like particles (VLPS) produced in transgenic plants (2022-09-06),

8. 11390878 - Increasing protein yield in plants (2022-07-19),

9. 11155581 - Increasing virus-like particle yield in plants (2021-10-26),

10. 11085049 - Influenza virus-like particle production in plants (2021-08-10),

11. 10590173 - Picornavirus-like particle production in plants (2020-03-17),

12. 10358652 - Influenza virus-like particle production in plants (2019-07-23),

13. 10272148 - Chimeric influenza virus-like particles comprising hemagglutinin (2019-04-30),

14. 10202423 - Picornavirus-like particle production in plants (2019-02-12),

15. 10190132 - Recombinant influenza virus-like particles (VLPs) produced in transgenic plants expressing hemagglutinin (2019-01-29),

Title: Manon Couture: Pioneering Innovations in Plant-Derived Protein Technology

Introduction: Manon Couture, a renowned inventor hailing from St-Augustin-de-Desmaures, CA, has made significant contributions to the field of plant-derived proteins through his innovative methods and patents.

Latest Patents: Couture's latest patents showcase his expertise in developing methods for preparing plant-derived proteins and virus-like particles (VLPs). These novel methods involve obtaining plant matter containing specific proteins, producing fractions, and recovering the desired proteins efficiently.

Career Highlights: With an impressive portfolio of 17 patents, Manon Couture has become a leading figure in the industry. His dedication to sustainable and advanced solutions has led to groundbreaking developments in plant-based protein technology.

Collaborations: Throughout his career, Couture has collaborated with esteemed organizations such as Medicago Inc. and Université Laval. Working alongside talented individuals like Louis-Philippe Vezina and Marc-André D'Aoust, he has explored new avenues in plant protein research.

Conclusion: In conclusion, Manon Couture stands as a beacon of innovation in the world of inventors, continually striving to create a more sustainable and technologically advanced future for generations to come. His groundbreaking work in plant-derived proteins and VLPs has paved the way for exciting possibilities in the field, solidifying his position as a visionary inventor shaping the landscape of modern biotechnology.

Profile summary based on public USPTO records.